Fiji Bur — Hermetica Encyclopedia
Herb · Pacific Islands

Fiji Bur (Tribulus terrestris)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Fiji Bur (Tribulus terrestris) contains steroidal saponins such as protodioscin and flavonoids including hesperetin (2321.29 μg/g dry weight) and quercetin (1770.84 μg/g), which modulate androgen receptors, inhibit apoptosis-related genes, and exert antioxidant effects through DPPH and ABTS radical scavenging. In vitro studies demonstrate cytotoxicity against HepG2 liver cancer cells at an IC₅₀ of 103.79 μg/mL and antibacterial activity with MIC values of 6.25–25 μg/mL, though robust human clinical trial data confirming therapeutic efficacy remain limited.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordFiji Bur Tribulus terrestris benefits
Fiji Bur close-up macro showing natural texture and detail — rich in dioscin), flavonoids (kaempferol, quercetin)
Fiji Bur — botanical close-up

Health Benefits

**Urinary Tract Support**
Saponins and flavonoids in Tribulus terrestris exert diuretic and antispasmodic effects on the urinary tract, consistent with its traditional Fijian use for urinary disorders; these compounds increase urine output and may reduce urinary crystal formation.
**Antioxidant Protection**
Methanol leaf extracts show DPPH radical scavenging with an IC₅₀ of 0.138 mg/mL and ABTS inhibition at IC₅₀ 0.287 mg/mL, primarily driven by phenolic compounds like chlorogenic acid (323.50 μg/g) and gallic acid (127.72 μg/g), which neutralize reactive oxygen species at the cellular level.
**Potential Anticancer Activity**
Leaf extracts induce cytotoxicity in HepG2 (IC₅₀ 103.79 μg/mL), MCF-7 (IC₅₀ 107.57 μg/mL), and HeLa (IC₅₀ 157.52 μg/mL) cancer cell lines by downregulating anti-apoptotic genes Bcl-2 and Bcl-xL; these findings are preclinical and require validation in human studies.
**Libido and Vitality Enhancement**
Steroidal saponins, particularly protodioscin, are proposed to modulate androgen receptor activity and may stimulate luteinizing hormone release, supporting traditional use as an aphrodisiac in Ayurveda and Pacific Island ethnomedicine; mechanistic evidence remains largely preclinical.
**Antimicrobial Action**
Leaf extracts demonstrate antibacterial activity against pathogens including Staphylococcus aureus, with MIC values ranging from 6.25 to 25 μg/mL, attributed to flavonoids and phenolic acids disrupting bacterial cell membrane integrity.
**Enzyme Inhibition and Anti-inflammatory Effects**
Extracts inhibit key inflammatory and metabolic enzymes at IC₅₀ values of 84–96.62 μg/mL, with campesterol (7.46% of leaf GC-MS peak area) and myricetin contributing to cyclooxygenase and lipoxygenase pathway modulation.
**Metabolic and Glycemic Support**
Traditional use in Ayurveda for diabetes management is supported by preliminary evidence that saponins and flavonoids may inhibit alpha-glucosidase activity and reduce oxidative stress in hyperglycemic states, though no controlled human trials have confirmed this application.

Origin & History

Fiji Bur growing in Africa — natural habitat
Natural habitat

Tribulus terrestris is a low-growing annual herb native to warm temperate and tropical regions spanning southern Europe, southern Asia, Africa, and the Pacific Islands, including Fiji where it is colloquially called Fiji Bur. It thrives in dry, disturbed, sandy, or poor soils and is commonly found along roadsides, coastal areas, and degraded grasslands. The plant has naturalized widely and is regarded as a weed in many agricultural regions, though it has been deliberately cultivated for medicinal use in Ayurvedic and traditional Pacific Island systems.

In Ayurvedic medicine, Tribulus terrestris has been used for over two millennia under the Sanskrit name Gokshura, meaning 'cow's hoof,' referencing the shape of its spine-bearing fruit; classical texts including the Charaka Samhita prescribe it for urinary calculi, impotence, and as a general tonic for the reproductive and urinary systems. Traditional Chinese Medicine employs the dried fruit (Ji Li) to pacify liver yang, improve vision, and treat urinary dysfunction, reflecting a parallel but distinct ethnomedicinal framework. In Fiji and broader Pacific Island ethnobotany, the plant is known as Fiji Bur and has been used in local healing traditions primarily for urinary complaints, with preparations typically involving aqueous decoctions of the fruit or leaves administered orally. The plant's widespread distribution and prolific spine-covered fruit—capable of injuring bare feet and livestock hooves—made it a highly recognizable and consistently documented medicinal species across Afro-Asian and Pacific traditional pharmacopoeias.Traditional Medicine

Scientific Research

The current evidence base for Tribulus terrestris is predominantly preclinical, consisting of in vitro cell culture and GC-MS/HPLC-DAD phytochemical characterization studies, with no large-scale randomized controlled trials identified in this literature set. In vitro cytotoxicity studies have quantified IC₅₀ values of 103.79–157.52 μg/mL across three human cancer cell lines and antioxidant IC₅₀ values as low as 0.138 mg/mL (DPPH) for methanol leaf extracts, providing mechanistically plausible but non-clinical data. Systematic reviews published up to 2010 noted preliminary evidence for aphrodisiac and vitality effects but explicitly called for well-designed randomized controlled trials, indicating the evidence gap has persisted. Geographic and varietal variability—illustrated by the difference in phytochemical profiles between Saudi Arabian leaf extracts and Pacific Island or South Asian ecotypes—further limits generalization of existing data to Fijian traditional use contexts.

Preparation & Dosage

Fiji Bur steeped as herbal tea — pairs with Tribulus terrestris is traditionally combined with Ashwagandha (Withania somnifera) in Ayurvedic rasayana formulations, where withanolide-mediated cortisol reduction may complement protodioscin-driven androgen receptor modulation, producing additive effects on vitality and stress resilience. Pairing with saw palmetto (Serenoa repens) is proposed for urinary tract support
Traditional preparation
**Standardized Extract Capsules**
250–750 mg per dose, 1–3 times daily; typically standardized to 40–60% saponins or 20–45% protodioscin content; most commonly used form in modern supplementation
**Whole Fruit/Seed Powder**
500–1500 mg daily in divided doses; less concentrated than extracts but contains the full spectrum of fatty acids, including oleamide (13
01%) and cis,cis-linoleic acid (12.05%) identified by GC-MS.
**Traditional Aqueous Decoction (Fijian/Ayurvedic)**
3–6 g) simmered in 300–500 mL water for 15–20 minutes; consumed twice daily for urinary complaints; preparation preserves water-soluble flavonoids and phenolic acids
Dried fruits or leaves (.
**Methanol/Ethanolic Tincture**
2–4 mL twice daily though oral bioavailability equivalence to in vitro data is unestablished
Research extracts demonstrate bioactivity at low μg/mL concentrations in vitro; commercial tinctures (1:5 ratio, 40–60% ethanol) are used at .
**Tea from Leaves**
2–4 g) steeped in boiling water for 10 minutes; delivers chlorogenic acid, gallic acid, and hesperetin; lower saponin content compared to fruit-based preparations
Dried leaf material (.
**Timing Note**
No evidence-based timing recommendations exist; with food is generally advised to minimize potential gastric irritation associated with saponin-rich preparations.

Nutritional Profile

Tribulus terrestris leaves are rich in flavonoids, with hesperetin at approximately 2321.29 μg/g, quercetin at 1770.84 μg/g, daidzein at 686.23 μg/g, and naringenin at 162.43 μg/g on a dry weight basis as determined by HPLC-DAD analysis. Phenolic acids present include chlorogenic acid (323.50 μg/g), cinnamic acid (230.94 μg/g), and gallic acid (127.72 μg/g), all contributing to the high total phenolic content of leaf versus seed fractions. Seeds contain significant fatty acid components, with GC-MS identifying cis,cis-linoleic acid at 12.05% peak area and oleamide at 13.01%, alongside the phytosterol campesterol at 7.46% in leaves. Steroidal saponins including furostanol-type saponins and protodioscin are present across fruit, leaf, and root fractions, with concentration varying by ecotype, season, and extraction solvent; oral bioavailability of saponins and flavonoids is subject to first-pass metabolism and gut microbiome hydrolysis, and precise human bioavailability data are not currently established.

How It Works

Mechanism of Action

The steroidal saponin protodioscin is hydrolyzed in the gut to yield active aglycones including diosgenin, which can interact with androgen receptors and stimulate luteinizing hormone secretion from the pituitary, potentially elevating testosterone indirectly; however, direct receptor binding affinities in humans remain poorly characterized. Flavonoids such as quercetin and hesperetin scavenge reactive oxygen species by donating hydrogen atoms to DPPH and ABTS radicals, and quercetin additionally inhibits pro-inflammatory enzymes including cyclooxygenase-2 and xanthine oxidase through competitive binding at their active sites. In cancer cell lines, leaf extract compounds downregulate the anti-apoptotic proteins Bcl-2 and Bcl-xL, tipping the balance toward caspase-dependent apoptosis as confirmed in HepG2, MCF-7, and HeLa cell assays. The diuretic mechanism underlying urinary benefit is attributed to increased glomerular filtration mediated by saponin-driven osmotic effects and potassium-sparing activity, though the precise renal molecular targets have not been fully elucidated in controlled pharmacological studies.

Clinical Evidence

No randomized controlled trials with defined sample sizes or formally reported effect sizes were identified in the current research context for Fiji Bur (Tribulus terrestris) as applied to its primary indications of urinary health, libido, or testosterone enhancement. Available quantitative data originate exclusively from in vitro experiments, including cytotoxicity assays (IC₅₀ 103.79–157.52 μg/mL), antioxidant assays (DPPH IC₅₀ 0.138–71.4 μg/mL across extract types), and antibacterial MIC determinations (6.25–25 μg/mL). Narrative reviews prior to 2010 acknowledged traditional and preliminary experimental support for aphrodisiac and diuretic properties but assessed confidence in clinical benefit as low due to absence of well-controlled human data. Overall, confidence in translating laboratory findings to patient-relevant clinical outcomes remains low, and the ingredient should be considered in the preliminary-to-moderate evidence category pending human trial data.

Safety & Interactions

At typical supplemental doses of 250–1500 mg daily, Tribulus terrestris is generally tolerated in short-term use, with reported adverse effects limited to mild gastric upset, nausea, and occasional sleep disturbances, consistent with saponin-induced gastrointestinal irritation. In vitro data indicate lower cytotoxicity in normal cells compared to cancer lines, suggesting a degree of selectivity, though this does not directly translate to established human safety thresholds. Potential drug interactions are theorized but not clinically characterized; androgenic saponin activity warrants caution when used concurrently with testosterone replacement therapy, anabolic steroids, or hormonal contraceptives, and diuretic effects may interact with antihypertensives and lithium clearance. Tribulus terrestris is contraindicated in pregnancy due to potential uterotonic and hormonal saponin activity supported by animal studies, and its use during lactation is not recommended due to insufficient safety data; individuals with hormone-sensitive conditions including prostate, breast, or uterine pathology should consult a clinician before use.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Tribulus terrestrisGokshuraJi LiPuncture VineCaltropDevil's WeedGoat's Head

Frequently Asked Questions

What is Fiji Bur used for in traditional Fijian medicine?
In traditional Fijian ethnomedicine, Fiji Bur (Tribulus terrestris) is primarily used for urinary complaints including dysuria, urinary calculi, and general urinary tract discomfort, consistent with its parallel use as Gokshura in Ayurveda. Preparations typically involve aqueous decoctions of the dried fruit or leaves, which deliver water-soluble flavonoids such as quercetin and phenolic acids including chlorogenic acid believed to contribute to diuretic and anti-inflammatory effects.
Does Tribulus terrestris actually increase testosterone levels?
The steroidal saponin protodioscin in Tribulus terrestris is proposed to indirectly elevate testosterone by stimulating luteinizing hormone release, but robust human clinical trial evidence confirming a meaningful increase in serum testosterone at standard supplemental doses (250–750 mg/day) is currently lacking. Systematic reviews have noted this evidence gap, and the majority of mechanistic support comes from animal studies and in vitro androgen receptor modulation assays rather than placebo-controlled human trials.
What are the main bioactive compounds in Tribulus terrestris?
The most pharmacologically significant bioactive compounds in Tribulus terrestris include steroidal saponins such as protodioscin and furostanol-type saponins, flavonoids including hesperetin (2321.29 μg/g dry weight), quercetin (1770.84 μg/g), and daidzein (686.23 μg/g), and phenolic acids like chlorogenic acid (323.50 μg/g) and gallic acid (127.72 μg/g) as quantified by HPLC-DAD in leaf extracts. Seeds additionally contain significant fatty acid fractions including cis,cis-linoleic acid (12.05%) and oleamide (13.01%) identified by GC-MS analysis.
Is Fiji Bur (Tribulus terrestris) safe to take daily, and are there any drug interactions?
Short-term daily use of Tribulus terrestris at 250–1500 mg is generally considered well-tolerated, with the most commonly reported side effects being mild gastrointestinal upset associated with saponin content. Potential drug interactions have not been formally characterized in clinical pharmacokinetic studies, but androgenic saponin activity warrants caution with hormone therapies and anabolic steroids, and diuretic properties may interact with antihypertensive agents and lithium; the herb is contraindicated during pregnancy due to possible uterotonic effects.
How should Tribulus terrestris be standardized when choosing a supplement?
High-quality Tribulus terrestris supplements are typically standardized to 40–60% total saponins or specifically to 20–45% protodioscin content, as saponins are considered the primary pharmacologically active fraction responsible for both the reputed androgenic and urinary tract effects. Leaf extracts generally contain higher total phenolic and flavonoid concentrations than seed extracts based on comparative phytochemical analysis, and consumers seeking antioxidant or anti-inflammatory benefits may prefer standardized leaf preparations, while traditional urinary and vitality applications historically use whole fruit decoctions or fruit-derived powders.
What is the difference between Tribulus terrestris fruit extract and leaf extract?
Fruit extracts are traditionally used and contain higher concentrations of saponins, which are primarily responsible for urinary and reproductive health benefits. Leaf extracts show stronger antioxidant activity with superior DPPH radical scavenging capacity (IC₅₀ of 0.138 mg/mL), making them preferable for antioxidant support, though both forms contain beneficial flavonoids and alkaloids. The choice between fruit and leaf depends on your primary health goal: reproductive support favors fruit extracts, while antioxidant protection favors leaf extracts.
What dosage of Tribulus terrestris is supported by clinical research?
Clinical studies examining reproductive and athletic performance outcomes typically used dosages between 750–1,500 mg daily of standardized extract, divided into 2–3 doses. For urinary tract support, traditional Fijian preparations used lower doses in herbal formulations rather than isolated supplements. Effective supplementation should use extracts standardized to 40–60% saponin content to ensure consistent bioactive compound levels across different batches.
Who should avoid Tribulus terrestris, and are there special populations with concerns?
Tribulus terrestris should be avoided by individuals with hormone-sensitive conditions (including estrogen-dependent cancers and prostate conditions) due to its traditional use for reproductive function, though human clinical evidence of hormonal effects remains mixed. Pregnant and breastfeeding women should consult healthcare providers before use, as safety data in these populations is limited. Individuals taking anticoagulants, antiplatelets, or blood pressure medications should use caution and seek professional guidance, as saponins may potentiate these effects.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.